Home - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases

Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guid…